Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 ...

Coloplast is now rated a cautious 'Buy,' as its valuation has become more reasonable after a significant price correction. Coloplast continues to deliver solid organic growth, boasts a wide economic ...

The wound healing devices market is largely propelled by the growing incidence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure sores, along with a rise in surgical ...

Coloplast AS (CLPBF) reports 7% organic growth amid strategic restructuring and market challenges, with a focus on technology and AI investments.

Detailed price information for Siemens Healthineers Ag (SEMHF) from The Globe and Mail including charting and trades.

Investing.com -- Coloplast delivered a solid fourth-quarter performance, with in-line organic sales growth (OSG) matching ...

SEBOKENG – A state-of-the-art stoma clinic was recently launched at Sebokeng Hospital. The clinic, a product of a collaboration between the hospital and Coloplast, supported by OMS Medical, will ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...